130 related articles for article (PubMed ID: 7340320)
1. [Glial migration inhibition test in multiple sclerosis patients and its changes during treatment with immunosuppressants].
Kogan OG; Kanchurin AKh; Kuznetsova OV; Brusina LI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1798-1802. PubMed ID: 7340320
[TBL] [Abstract][Full Text] [Related]
2. [Immunosuppressive treatment im multiple sclerosis].
Mertin J
Fortschr Med; 1980 Oct; 98(37):1431-6. PubMed ID: 6253370
[TBL] [Abstract][Full Text] [Related]
3. [The problem and value of therapy in multiple sclerosis].
Hitzschke B; Meyer-Rienecker HJ; Buddenhagen F; Richter M
Psychiatr Neurol Med Psychol (Leipz); 1988 Oct; 40(10):598-608. PubMed ID: 3237866
[TBL] [Abstract][Full Text] [Related]
4. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
Hauser SL; Fosburg M; Kevy S; Weiner HL
Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
[TBL] [Abstract][Full Text] [Related]
5. [Etiopathogenic problems in multiple sclerosis. Etiology, pathogenesis and therapeutic concept].
Meyer-Rienecker H; Hitzschke B
Nervenarzt; 1974 Mar; 45(3):133-41. PubMed ID: 4598802
[No Abstract] [Full Text] [Related]
6. [Clinical picture and therapy of multiple sclerosis].
Schrader A
Wien Med Wochenschr; 1972 Mar; 122(10):129-34. PubMed ID: 4334261
[No Abstract] [Full Text] [Related]
7. New treatments for multiple sclerosis.
Hallpike JF
Br J Hosp Med; 1980 Jan; 23(1):63-4, 66, 68. PubMed ID: 6153540
[No Abstract] [Full Text] [Related]
8. [Experiences with the indirect Clausen Test using NTA as an antigen in multiple sclerosis and other neurologic diseases].
Dachsel R; Felber F; Liebert A
Psychiatr Neurol Med Psychol (Leipz); 1984 Jun; 36(6):350-6. PubMed ID: 6484061
[TBL] [Abstract][Full Text] [Related]
9. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
Dachsel R; Köppel C
Psychiatr Neurol Med Psychol (Leipz); 1989 Jul; 41(7):420-5. PubMed ID: 2772076
[TBL] [Abstract][Full Text] [Related]
10. [Immunosuppressants and multiple sclerosis].
Ruiz-Peña JL; Izquierdo-Ayuso G
Rev Neurol; 2002 Aug 16-31; 35(4):373-80. PubMed ID: 12235571
[TBL] [Abstract][Full Text] [Related]
11. [Immunodepressants used in immune system pathology. II. Methotrexate, vinblastine, antilymphocyte serum and prednisolone].
Napolov IuK; Borisov KB
Farmakol Toksikol; 1991; 54(5):78-85. PubMed ID: 1800160
[No Abstract] [Full Text] [Related]
12. [The effect of prednisolone on the immunoglobulin content of the blood in patients with disseminated sclerosis].
Iarosh AA; Prokopiv MM; Zhovnir IK; Kanevskaia SA
Vrach Delo; 1990 Aug; (8):70-2. PubMed ID: 2256298
[TBL] [Abstract][Full Text] [Related]
13. [Therapy of multiple sclerosis].
Simó M
Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
[TBL] [Abstract][Full Text] [Related]
14. [New therapeutic possibilities for disseminated sclerosis?].
Wanscher B; Sørensen PS
Ugeskr Laeger; 1994 Oct; 156(43):6353-8. PubMed ID: 7810008
[TBL] [Abstract][Full Text] [Related]
15. [Immunosuppressive medication in multiple sclerosis].
García Merino JA
Rev Neurol; 2002 Dec 16-31; 35(12):1154-8. PubMed ID: 12497298
[TBL] [Abstract][Full Text] [Related]
16. [Blood levels of soluble ICAM-1 in patients with multiple sclerosis].
García-Tortosa C; Amrani Y; Casado A; Muñoz FJ; Vázquez J
Rev Neurol; 1998 Jun; 26(154):926-9. PubMed ID: 9658462
[TBL] [Abstract][Full Text] [Related]
17. Natalizumab: new drug. Multiple sclerosis: risky market approval.
Prescrire Int; 2008 Feb; 17(93):7-10. PubMed ID: 18354844
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of multiple sclerosis with antilymphocyte serum: results of a pilot study on 50 patients followed-up over a 4-year period (author's transl)].
Lhermitte F; Marteau R; De Saxce H
Rev Neurol (Paris); 1979 Jun; 135(5):389-400. PubMed ID: 538387
[TBL] [Abstract][Full Text] [Related]
19. [Immunsuppressive treatment of multiple sclerosis. 2. Critical review of general results (author's transl)].
Frick E; Angstwurm H; Strauss G
MMW Munch Med Wochenschr; 1974 Nov; 116(45):1987-92. PubMed ID: 4216803
[No Abstract] [Full Text] [Related]
20. Autologous stem-cell transplantation in malignant multiple sclerosis: a case with a favorable long-term outcome.
Kimiskidis V; Sakellari I; Tsimourtou V; Kapina V; Papagiannopoulos S; Kazis D; Vlaikidis N; Anagnostopoulos A; Fassas A
Mult Scler; 2008 Mar; 14(2):278-83. PubMed ID: 17942513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
